Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

BackgroundWhether non–vitamin K antagonist oral anticoagulants (NOACs) are superior to warfarin among Asians with nonvalvular atrial fibrillation remains unclear. Methods and ResultsIn this nationwide retrospective cohort study collected from Taiwan National Health Insurance Research Database, there...

Full description

Bibliographic Details
Main Authors: Yi‐Hsin Chan, Lai‐Chu See, Hui‐Tzu Tu, Yung‐Hsin Yeh, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Chun‐Li Wang, Chang‐Fu Kuo, Chi‐Tai Kuo
Format: Article
Language:English
Published: Wiley 2018-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
atrial fibrillation
direct thrombin inhibitor
factor Xa inhibitor
hemorrhage
ischemic stroke
mortality
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.008150

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.008150

Similar Items